The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The ACR President Joseph Flood, MD, Reviews 2014 in Rheumatology

The ACR President Joseph Flood, MD, Reviews 2014 in Rheumatology

November 1, 2014 • By Joseph Flood, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The Annual Meeting

For many people, the Annual Meeting and the ACR are the same thing. “Are you going to ACR this year?” is the way we inquire about whether you will join us in Boston. The meeting is a complex undertaking to create, requiring the work of countless volunteers, ACR staff and temporary staff. In January, I attended the first two days of the Annual Meeting Planning Committee’s work. I was overwhelmed by the wealth of science we present in a compressed amount of time. I was bewildered by how this large group of people emerged from the meeting with the complicated schedule of sessions we all love. How we can meet the expectations of a wide variety of scientists and practitioners from around the globe and prevent important content from overlapping with other important content for each of these groups seems like magic to me.

You Might Also Like
  • Incoming ACR President Joseph Flood, MD, Maps Out the Year Ahead
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
  • President’s Perspective: The ACR’s RISE Registry Will Simplify Reporting, Comparing Clinical Data
Explore This Issue
November 2014
Also By This Author
  • Update on Legislation, Advocacy Efforts to Advance Rheumatology

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
The ACR Board of Directors and committee chairs.
The ACR Board of Directors and committee chairs.

Attacks Thwarted

During this year, the ACR tackled multiple attacks on the ability of rheumatologists and rheumatology health professionals to operate effective and profitable enterprises. Whether it is the daily care of patients or work in the laboratory, our ability to do what we love and what patients need is being pummeled. We have seen a federal government that seems uninterested in supporting the medical scientific community.

The funding by the federal government of rheumatology research is dwindling, and this compromises the careers of promising scientists. The portion of NIH grants awarded to rheumatology is unacceptable. The Committee on Research has vigorously requested more information on the grants-making process to better understand how these grants are distributed and to ensure rheumatology is fairly treated. Our advocates constantly press the need for more support for research.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

CMS and other insurers are threatening our ability to give quality care to our patients. Some Medicare contractors have threatened to deny the professional administration of certain medications that can be self-administered by able patients. CMS will not understand that some patients simply cannot afford the cost of biologics covered under Part D and must use Part B to access effective treatment. Some Medicare contractors want to deny the costs associated with the infusion of the complex medications we use so effectively and safely to improve people’s lives.

We have even seen one insurer try to ration biologic care based on the deals they can achieve with manufacturers, not on the basis of what is right for the patient. A scheme was proposed to change stable patients to a different biologic medication based solely on the cost to the insurer. The ACR adamantly and successfully opposed this irrational threat to our patients.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Conditions, Electronic Health Records, Legislation & Advocacy, Osteoarthritis, President's Perspective, Professional Topics, SLE (Lupus), Technology Tagged With: AC&R, ACR/ARHP Annual Meeting, Advocacy, American College of Rheumatology, collaboration, Cutolo, electronic health record, EULAR, Flood, glucocorticoid, Henkel, Legislation, Lupus, Medicare, Osteoporosis, rheumatologist, rheumatology, TechnologyIssue: November 2014

You Might Also Like:
  • Incoming ACR President Joseph Flood, MD, Maps Out the Year Ahead
  • ACR Aims to Keep Rheumatology on Congressional Radar in 2014
  • President’s Perspective: The ACR’s RISE Registry Will Simplify Reporting, Comparing Clinical Data
  • The 2014 ACR/ARHP Annual Meeting Offers Programs for Rheumatology Clinicians, Researchers, Practice Management Professionals

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)